TrialBMJ open diabetes research & care2022

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.

Richard E Pratley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.